PurePharmas offers high-purity Retatrutide also known as the Triple G agonist for advanced metabolic research and in vitro studies. This innovative synthetic peptide is a triple hormone receptor agonist targeting the glucagon-like peptide-1 GLP-1 glucose-dependent insulinotropic polypeptide GIP and glucagon GCG receptors. Our Retatrutide is synthesized to reach a 99% purity level as verified by RP-HPLC and mass spectrometry ensuring the highest chemical integrity for preclinical laboratory investigations. Each vial contains lyophilized Retatrutide powder vacuum-sealed in a sterile environment to maintain stability during global transit and long-term storage. This compound is a primary tool for researchers exploring synergistic effects on thermogenesis energy expenditure and glycemic control in cellular models. PurePharmas provides comprehensive COA documentation with every batch to support rigorous scientific transparency.
![]()
Peptides

